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ABSTRACT
Objective: To summarise the evidence regarding the
effectiveness of integrated care interventions in
reducing hospital activity.
Design: Umbrella review of systematic reviews and
meta-analyses.
Setting: Interventions must have delivered care
crossing the boundary between at least two health and/
or social care settings.
Participants: Adult patients with one or more chronic
diseases.
Data sources: MEDLINE, Embase, ASSIA, PsycINFO,
HMIC, CINAHL, Cochrane Library (HTA database,
DARE, Cochrane Database of Systematic Reviews),
EPPI-Centre, TRIP, HEED, manual screening of
references.
Outcome measures: Any measure of hospital
admission or readmission, length of stay (LoS),
accident and emergency use, healthcare costs.
Results: 50 reviews were included. Interventions
focused on case management (n=8), chronic care
model (CCM) (n=9), discharge management (n=15),
complex interventions (n=3), multidisciplinary teams
(MDT) (n=10) and self-management (n=5). 29 reviews
reported statistically significant improvements in at
least one outcome. 11/21 reviews reported significantly
reduced emergency admissions (15–50%); 11/24
showed significant reductions in all-cause (10–30%) or
condition-specific (15–50%) readmissions; 9/16
reported LoS reductions of 1–7 days and 4/9 showed
significantly lower A&E use (30–40%). 10/25 reviews
reported significant cost reductions but provided little
robust evidence. Effective interventions included
discharge management with postdischarge support,
MDT care with teams that include condition-specific
expertise, specialist nurses and/or pharmacists and
self-management as an adjunct to broader
interventions. Interventions were most effective when
targeting single conditions such as heart failure, and
when care was provided in patients’ homes.
Conclusions: Although all outcomes showed some
significant reductions, and a number of potentially
effective interventions were found, interventions rarely
demonstrated unequivocally positive effects. Despite
the centrality of integrated care to current policy,
questions remain about whether the magnitude of
potentially achievable gains is enough to satisfy
national targets for reductions in hospital activity.
Trial registration number: CRD42015016458.
INTRODUCTION
Hospital activity continues to rise and cur-
rently accounts for almost half of annual
NHS expenditure.1 Demands on the acute
sector are strongly inﬂuenced by the rapidly
growing number of patients with multiple,
chronic health conditions. These patients
often need to access multiple health and
social care settings but typically experience
fragmented and poorly coordinated care.2 3
Reducing hospital activity is seen as the key
to relieving pressure on services that are
rapidly approaching their limits,4 and inte-
grated care has become a cornerstone of the
policy response to this challenge in the UK
and most other developed countries.
Integrated care represents an organising
principle for care delivery that aims to
Strengths and limitations of this study
▪ This umbrella review is the first of its kind since
integrated care became central to healthcare
policy.
▪ Outcomes were selected following consultation
with service providers, commissioners and
patient representatives to ensure relevance.
▪ We assessed a large volume of international evi-
dence across diverse chronic conditions, inter-
ventions and outcomes.
▪ Umbrella reviews do not allow conclusions to be
drawn about the detailed contexts in which inter-
ventions were implemented, but they do permit a
broader overview of the evidence base than
would be possible with a focus on primary
research alone.
▪ Heterogeneity of intervention design, duration,
intensity and follow-up prohibited meta-synthesis
across reviews.
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improve patient experience of services through
improved coordination across and between settings.5 By
facilitating more patient contact, treatment and
follow-up in primary care, in the community or in
patients’ homes, integration aims to reduce substantially
the number of emergency and other admissions to hos-
pital and facilitate timely and effective discharge from
hospital to other settings. Following the establishment of
a series of integrated care ‘pioneers’ in 2013, hospital
trusts and commissioning organisations in England are
planning and investing in a plethora of integrated ser-
vices via the Better Care Fund (BCF), which aims to
promote joint working at a strategic and operational
level.6 Following the NHS Five Year Forward View,7 there
are also proposals to develop and implement new
models of care with integration as their central
principle.8
Integration undoubtedly has laudable aims—poor
care coordination is often the main problem cited by
patients when describing their experiences of health
and social care services.9 10 NHS staff also welcome inte-
gration,11 12 yet evidence about the effectiveness of inte-
grated care in reducing healthcare resource use,
particularly within the acute sector, is limited. Integrated
care programmes can have a positive effect on service
quality,13 and there is emerging evidence from recent
evaluations of integrated care pilots that suggests poten-
tial for service efﬁciencies.14 15 However, there is still
uncertainty about which interventions are most effective
and how these should be implemented,16 alongside per-
sistent questions over whether the aims of integration
are ultimately achievable in any meaningful way.17 Given
this uncertainty, it is timely to assess the evidence. This
paper reports the ﬁndings of an umbrella review of the
evidence for integrated care interventions operating
across health and/or social care settings for chronic
disease management in order to assess: (1) whether
integration reduces hospital activity, (2) which interven-
tions are the most promising, for which patients and in
which settings, and (3) what are the associated cost
implications.
METHODS
Umbrella reviews synthesise evidence from multiple sys-
tematic reviews into a single ‘meta review’, using the
ﬁndings and conclusions of included systematic reviews
as the raw data. They are useful when the evidence base
is broad and are of particular importance for decision
makers who need a synthesis of the most current and
reliable data relevant to their context.18 The protocol
was published19 and registered on PROSPERO.
Inclusion criteria
We included systematic reviews and meta-analyses pub-
lished since January 2000 that evaluated interventions
designed to facilitate integrated health and/or social
care services. The year 2000 was chosen following
scoping searches that indicated little or no systematic
review evidence for integrated care interventions before
this date. Eligible reviews could include primary studies
of any experimental or quasi-experimental study design,
providing the authors had identiﬁed studies using sys-
tematic methods. Eligibility was limited to reviews avail-
able in English.
Participants included adult patients with one or more
chronic conditions. A list of 11 speciﬁc conditions was
derived following a scoping review and combined a
series of conditions recommended as central to any sys-
tematic review of chronic disease20 21 and those
included in the most recent Health Survey for
England.22 The resulting conditions (hypertension,
depression, diabetes, coronary heart disease, stroke, tran-
sient ischaemic attack, chronic obstructive pulmonary
disease (COPD), cancer, heart failure, dementia and
arthritis) covered those that are most prevalent within
the adult population, most costly to manage and most
likely to occur in combination with other chronic
conditions.
Interventions could be implemented in any health or
social care setting (primary, secondary or community
care), as long as they crossed the boundary between two
or more settings. The community setting encompassed
care given in the community, in patient homes or by
social care professionals. Exclusion criteria were: pallia-
tive care interventions; purely psychosocial interventions
or those related to spirituality, mindfulness, health liter-
acy or the use of complementary and alternative medi-
cines; interventions focusing solely on diet and lifestyle
factors; treatment or medication adherence; the effect-
iveness of surgical or diagnostic techniques; caregivers;
pregnancy, and interventions implemented in less eco-
nomically developed countries.
Comparison groups could include usual care, no inter-
vention or comparison to one or more other
interventions.
Outcome measures
Outcome measures were selected following a scoping
review, a stakeholder workshop attended by service provi-
ders and commissioners and consultation with a group
of patient and public involvement (PPI) advisors.
Eligible reviews assessed one or more of the following
outcomes: acute sector activity (emergency hospital
admissions/readmissions, length of hospital stay, acci-
dent and emergency (A&E) use) and healthcare costs.
Search strategy
The search strategy was intentionally broad and included
general terms related to chronic disease, multimorbid-
ities and long-term conditions as well as MeSH terms for
the 11 speciﬁc chronic diseases identiﬁed from scoping
searches. Search terms associated with integrated care
and known interventions were also included. A separate
search identiﬁed systematic reviews that assessed the cost
implications of integrated care interventions (see online
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supplementary information for MEDLINE search
strategy).
Relevant reviews were identiﬁed by searching elec-
tronic bibliographic databases and the manual checking
of each included review’s reference list. We searched
MEDLINE, Embase, ASSIA (Applied Social Sciences
Index and Abstracts), PsycINFO, Health Management
Information Consortium database (HMIC), CINAHL,
Cochrane library (including the Health Technology
Assessment (HTA) database, Cochrane Database of
Systematic Reviews, Database of Abstracts of Reviews of
Effectiveness—DARE), EPPI-Centre library, TRIP data-
base and the Health Economics Evaluations Database
(HEED). Searches were performed in July 2014 and
updated in December 2015.
Eligibility assessment and data extraction
Two authors (SD and SF) independently screened titles
and abstracts against the inclusion and exclusion cri-
teria, and full text copies of all potentially relevant
reviews were assessed. Disagreements were resolved
through the independent assessment of a third author
(GC). Where multiple versions of an eligible review were
available, the most recent or most comprehensive
version was included. Where the same review was pub-
lished more than once (eg, Cochrane Collaboration
review and subsequent update), the updated version was
included. Data on review characteristics (databases
searched, geographical scope, healthcare settings and
disease(s) focused on), methodology (aim, research
questions, number of studies included, review type),
study participants, interventions and outcomes of inter-
est were extracted from each included review and cross-
checked by SD and SF according to a predeﬁned data
extraction sheet. For narrative reviews, a statement sum-
marising the authors’ primary interpretation of ﬁndings
was extracted. For meta-analyses, data on relative risks or
ORs were extracted along with the corresponding 95%
CIs.
Quality assessment
Review quality was appraised independently by SD and
SF using the Centre for Evidence-Based Medicine
(CEBM) tool for critical appraisal of systematic reviews
(http://www.cebm.net/wp-content/uploads/2014/04/SR_
Appraisal_sheet_2005_English.doc) which scores each
review between 0 (poor quality) and 5 (high quality).
Using quality score as an exclusion criterion was not part
of the protocol, but considerable quality differences were
evident between reviews scoring 0 to 2.5 and those scoring
3 or above. Lower quality reviews had little (if any) extract-
able outcomes data so we decided to exclude reviews
scoring 2.5 or less on the quality scale.
Data analysis
Heterogeneity in study populations, interventions
assessed, follow-up periods and speciﬁcation of control
groups prevented pooling of intervention effects and
quantitative meta-synthesis across reviews. Owing to this,
and to avoid the risk of ‘double counting’ evidence
where multiple reviews contained some of the same
primary studies, our synthesis was a primarily narrative
review of interventions and outcomes. The strength of
evidence from each meta-analysis or narrative review was
characterised according to four categories: deﬁnite posi-
tive or negative associations, mixed ﬁndings or no associ-
ation (table 1).
RESULTS
Figure 1 summarises the search. A total of 11 436 poten-
tially eligible reviews were identiﬁed, and 50 (in 49
papers) were included (table 2). A total of 1208 individ-
ual primary studies were included in the reviews
(median 19, range 4–153). Nineteen reviews did not
specify patient numbers, but across the 31 that did, all
Table 1 Categorisation of the strength of effect for included reviews
Category Symbol Interpretation
Positive
association
+ At least half of a review’s included primary studies showed a statistically significant increase in
a particular outcome following the intervention; the authors’ summary of findings (narrative
reviews) demonstrated a positive association, or pooled results from a meta-analysis indicated
a statistically significant positive association, eg, hospital admission rates significantly
increased.
Negative
association
− At least half of a review’s included primary studies showed a statistically significant decrease in
a particular outcome following the intervention; the authors’ summary of findings (narrative
reviews) demonstrated a negative association, or pooled results from a meta-analysis indicated
a statistically significant negative association, eg, hospital admission rates significantly
reduced.
Mixed findings ? A review reported mixed findings, in which some primary studies may have shown a
statistically significant difference between intervention and control groups whereas other
primary studies showed no significant differences between groups.
No association = A review where no significant differences between intervention and control groups were
reported in any of the included primary studies.
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but three included 1000 or more patients (total 219 475,
median 2692, range 857–78 590). Studies within reviews
varied in duration from 2 weeks to 60 months, with most
lasting up to 12 months, although 9 reviews did not
specify follow-up duration. Furthermore, 21 reviews were
narrative,23–42 26 included meta-analyses43–68 and 3 were
reviews of reviews.69–71
The most commonly studied condition was chronic
disease (n=15),23–28 37 39–41 43 57 69 70 followed by heart
failure (n=14),36 42 45 47 53 55 58 59 61–66 COPD
(n=12),29 33 38 44 46 48–50 54 60 67 68 stroke
(n=5),31 34 35 52 56 stroke and cardiac conditions
(n=2),30 32 mental health (n=1)51 and heart failure and
COPD combined (n=1).71 All reviews were published
between 2004 and 2015. Reviews were published
in Canada,26 31 37 38 41 42 57 63 65–67 71 the UK,24
43–45 52 56 60–62 64 the USA,23 30 32 33 46 51 53 58 59 the
Netherlands,25 27–29 34 48 49 68 Ireland,39 40
Switzerland,50 70 Norway,54 Japan,69 Hong Kong,36
Spain,47 Denmark35 and Greece.55 In most reviews, the
comparator was usual clinical care, although a detailed
description of usual care was typically not provided.
Overall, 29 reviews (58%) reported a nominally statistic-
ally signiﬁcant result for at least one outcome.
Quality of included reviews
The mean quality assessment (QA) score was 4/5.
Twelve reviews scored 5/5 (24%).39 40 48 49 51 56
58 61 62 66 68 The criterion for which the largest number
of reviews failed to score a point related to whether a
valid consideration of bias across primary studies had
been undertaken. There was no discernible trend
in review quality across intervention categories: the
mean QA scores by the intervention group ranged
from 3.4/5 (case management) to 4.2/5 (chronic care
model (CCM), multidisciplinary teams (MDT), self-
management).
Effects by intervention type
Interventions were categorised into six broad groups
(table 3), although intervention components frequently
overlapped.
Eight reviews focused on case management interven-
tions.23–27 43–45 With the exception of one review which
showed that case management was associated with sig-
niﬁcantly reduced healthcare costs,26 and another that
demonstrated a 49% relative risk reduction (RRR) in
admissions for patients with heart failure,45 all case
management reviews showed mixed ﬁndings or no
Figure 1 PRISMA diagram of
search results.
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Table 2 Characteristics of included reviews
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Case management
Hickam et al (2013);23
USA
RCTs,
observational
n=153
Not specified
5 databases,
inception—2011
Chronic disease
Adult patients with
complex care
needs
Narrative
Care without a case
management
component
4
6–36 months
Intensive interventions: multiple
face-to-face interactions, home
visits vs less intensive
interventions: infrequent contact
Delivered by case managers
working alone or within a MDT of
health professionals.
Primary, secondary, community
Admissions: 2 studies found case
management to be more effective
in patients with greater disease
burden. A further 4 studies found
case management to be effective
when case managers have greater
levels of personal contact with
patients (low quality evidence).
Costs (4 studies): 3 found no
difference between groups. One
study found higher overall costs in
intervention group vs control.
Hutt et al (2004);24 UK RCTs, CCTs,
before/after n=20
n=18 002
‘Major’ databases,
1996–2004
Chronic disease
Over 65s with any
chronic condition
(mental health
excluded)
Narrative
Care without a case
management
component
3
At least 3 months
Home visits and/or periodic
reassessment, ranging from case
manager assessment at hospital or
home with occasional telephone
contact, to regular intensive contact
where case managers arranged
medical appointments and were
contactable 24/7.
Delivered by case manager (nurse
or social worker).
Primary, secondary, community.
Admissions (18 studies): 5 showed
a significant reduction in
admissions in intervention groups;
7 found no difference between
groups; 4 found non-significant
reductions, 2 found non-significant
increases in admissions in the
intervention group
LoS (16 studies): 3/16 showed
significant decrease, 2/16 showed
non-significant increase, 11/16
showed no differences.
A&E use (8 studies): 3 showed
significant reduction, 2 showed
significant increases, 2 showed
non-significant increases.
Costs (10 studies): 4 showed
non-significant increases in
intervention; 6 reported reductions
although only 1 was significant.
Latour et al (2007);25
Netherlands
RCTs, CCTs,
before/after n=10
n=5092
4 databases,
inception-2005
Chronic disease
Adult patients with
acute or chronic
conditions
Narrative
Care without a case
management
component
3
3–18 months
Postdischarge nurse-led case
management for complex patients,
delivered in the outpatient setting.
Needs assessment, service plans,
monitoring, assessment,
evaluation, follow-up via home
Readmissions (9 studies): 3 high
quality, 1 low quality reported
positive results for intervention.
4 studies (2 high quality) showed
no difference between groups;
1 presented insufficient data.
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
visits and/or telephone.
Secondary, community
LoS (6 studies): 2 showed
significant reduction, 2 showed
non-significant reduction, 2 showed
no difference between groups.
A&E use (4 studies): Strong
evidence that intervention had no
significant impact.
Manderson et al (2012);26
Canada
RCTs n=15
n=2317
5 databases,
1999–2011
Chronic disease
Older people
Narrative
Not specified
3
1–18 months
Care planning and coordination via
phone support, home visits, liaison
with medical and community
services and/or education. APN,
care coordinators, case managers.
Primary, secondary, community
Costs (9 studies): 5 reported
positive economic outcomes, 4 did
not. Specific data and effect sizes
not given.
Oeseburg et al (2009);27
Netherlands
RCTs n=9
n=15 746
3 databases,
1995–2007
Chronic disease
Community
dwelling patients
Narrative
Care without a case
management
component
3
10–36 months
Home visits and/or telephone calls.
Delivered by a case manager
(nurse, social worker or nurse
practitioner) who was either a
member of a MDT or acted
independently.
Primary, secondary, community
Admissions (6 studies): 1 showed
small reduction in favour of
intervention (good quality). One
found small increase in intervention
group (weak quality).
LoS (5 studies): One reported
small reduction in days per year in
hospital in intervention group.
A&E use (5 studies): One reported
small reduction in intervention,
1 reported an increase. 3 reported
no difference.
Costs (3 studies): 1 reported
significant but trivial saving in
intervention. Another found 19%
cost reduction due to savings in
nursing home, hospital and
community costs. A third found
costs to be higher in intervention
(non-significant).
Stokes et al (2015);43 UK RCTs, CCTs,
before/after, time
series n=36
n=23 711
6 databases,
inception-2014
Chronic disease
Adult patients with
chronic diseases
SR and
meta-analysis
Care without a case
management
component
4
6–60 months
Community-based MDTs
responsible for delivering and
coordinating services; MDT care
plan following case worker
assessment, case manager
constantly available to deal with
problems.
Costs: No significant effects found:
Short term (0–12 months): SMD
−0.00 CI −0/07 to 0.06
Longer term (13+ months): SMD
−0.03 CI −0.16 to 0.10
Continued
6
Dam
ery
S,etal.BM
J
Open
2016;6:e011952.doi:10.1136/bm
jopen-2016-011952
O
p
e
n
A
c
c
e
s
s
group.bmj.com
 o
n
 N
ovem
ber 22, 2016 - Published by 
http://bmjopen.bmj.com/
D
ow
nloaded from
 
Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Delivered by care manager, nurse,
pharmacist, GP collaborating with
nurse.
Primary, community
Taylor et al (2005);44 UK RCTs n=9
n=1428
24 databases,
1980–2005
COPD
Patients with
COPD in the
community
SR and
meta-analysis
Conventional
postdischarge care
4.5
3–12 months
Brief (1 month) or longer term
(12 months) inpatient, outpatient or
community-based interventions. All
were led, coordinated or delivered
by respiratory nurses via home
visits, with or without telephone
follow-up.
Primary, secondary, community
Readmissions: Equivocal evidence
for reduction in all-cause
readmission at 12 months. One
study found a 40% reduction in
readmission for acute exacerbation
and 57% reduction in all-cause
readmission. Another found a
significant reduction in
readmissions. Three further studies
found no effect.
Thomas et al (2013);45
UK
RCTs n=10
Not specified
18 databases,
inception-2010
Heart failure
Adult patients
SR and
meta-analysis
Not specified
3
3–18 months
Specialist HF management
education:
1. Intensive: 4–6-week
appointments
2. Decreasing intensity: every
1–2 weeks for 3 months, then
every 3 months
3. Regular: 3–4-month
appointments
4. Tailored: appointments by
patient need
5. Primary, secondary
Admissions:
At 3 months (RR 0.10, 95% CI
0.01 to 0.78).
At 12 months (5 studies), 49%
reduction in relative risk (RR 0.51,
95% CI 0.41 to 0.63).
At 18 months (1 study), no
difference between groups.
Interventions with decreasing
intensity showed 58% reduction
(RR 0.42, 95% CI 0.27 to 0.65). No
significance for other groups.
Chronic care model
Adams et al (2007);46
USA
RCTs n=32
Not specified
3 databases,
inception-2005
COPD
Adult patients with
COPD
SR and
meta-analysis
Not specified
4
6 weeks to 24 months
At least one component of
Wagner’s CCM. Categorised
according to the number of
components an intervention
included.
Primary, secondary, community
Admissions: No difference in rates
for interventions with 1 CCM
component (n=7). Significant
reduction for interventions with
multiple CCM components (n=4);
RR 0.78, 95% CI 0.66 to 0.94).
LoS:
1 CCM component (4 studies): No
difference between groups.
Multiple components (2 studies):
Significant reduction in intervention
(−2.51 days, 95% CI −3.40 to
−1.61).
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
A&E use: 3 studies with 2+ CCM
components found statistically
significant reduction (RR 0.58, 95%
CI 0.42 to 0.79).Costs (7 studies):
3 RCTs showed 34% to 70% cost
reduction with intervention. One
RCT showed non-significant cost
reductions. Three before/after
studies reported an 11% to 23%
reduction in costs after
intervention.
de Bruin et al (2012);28
Netherlands
RCTs, CCTs,
before/after,
case–control n=41
n=78 590
6 databases,
1995–2011
Chronic disease
Adult patients with
multiple chronic
conditions
Narrative
Not specified
4.5
Not specified
Studies categorised by number of
CCM components they included.
Multiple settings, from home care
organisations and community
centres to primary care, hospitals,
specialist clinics. Some included
newly established partnerships;
others provided regular care in
settings where it was not normally
given.
Primary, secondary, community
Admissions: 3/16 studies found
significantly reduced admissions.
Costs (5 studies): All reported
negative incremental direct
healthcare costs for patients
receiving intervention. Costs
ranged from −US$5708 to −US
$204 per patient per year, primarily
due to lower inpatient costs in the
intervention group.
Gonseth et al (2004);47
Spain
RCTs, CCTs,
n=27
Not specified
3 databases,
inception-2003
Heart failure
Over 65s with
principle or
secondary
diagnosis of HF
SR and
meta-analysis
Care without a CCM
component
4.5
3–48 months
Education, counselling, diet advice,
self-care support, discharge
planning, focus on hospital to
home transition, medication
management, clinic review, GP
follow-up.
Most delivered by nurses. Varied
timing (eg, in-hospital or
postdischarge), organisation (eg,
home care or outpatient clinic visit),
duration (from single home visit to
intensive intervention lasting
12 months).
Primary, secondary, community
Readmissions: Reduced
regardless of follow-up length or
whether intervention delivered at
home or in clinic setting.
All-cause (6 studies): 15%
reduction in readmissions
(RR 0.85, 95% CI 0.79 to 0.92).
HF-specific (6 studies): 30%
reduction in readmissions (RR
0.70, 95% CI 0.62 to 0.79).
Costs (11 studies): 10 estimated
the intervention reduced costs.
One reported similar costs in
intervention and usual care groups.
Hisashige (2013);69
Japan
SR and
meta-analyses
n=28
Chronic disease
Adult patients
Review of reviews
Not specified
3.5
Not specified
All interventions had 1+ CCM
component. Typically
multidisciplinary approaches with
Admissions (22 studies):
‘Improvement with a reasonable
amount of evidence’ with
Continued
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Not specified
9 databases,
1995–2010
clinical follow-up by specialists,
home visits, hospital discharge
planning or postdischarge
follow-up, counselling in hospital
and patient education or reminders.
Primary, secondary, community
intervention seen in 63% of studies
(14/22).
Costs (16 studies): 6/16 (38%)
observed ‘improvement in costs
with a reasonable amount of
evidence’. Costs tended to focus
on healthcare costs and typically
did not include estimates of
intervention costs.
Kruis et al (2013);48
Netherlands
RCTs n=26
n=2997
5 databases,
1990-present
COPD
Adult patients with
clinical diagnosis
of COPD
SR and
meta-analysis
Regular follow-up visits
to healthcare providers
5
3–24 months
Multidisciplinary (2+ providers),
multitreatment (2+ CCM
components), 3+ months duration.
Categorised as:
1. Exercise dominant
2. Self-management dominant
3. Structured nurse/GP follow-up
4. Exercise and self-management
5. Self-management+structured
follow-up
6. Individually tailored education
Primary, secondary, community
Admissions: All-cause: number of
participants with one or more
admissions over 3–12 months was
27 per 100 in control vs 20 per 100
in intervention (OR 0.68, 95% CI
0.47 to 0.99, p=0.04).
Respiratory related: at 3 months
(7 studies), significant reduction
(0.68, 95% CI 0.47 to 0.99,
p=0.04). At 12 months (1 study), no
difference observed.
LoS: Significantly lower in the
intervention group. Mean difference
−3.78 days (95% CI −5.90 to
−1.67, p<0.001).
Lemmens et al (2009);49
Netherlands
RCTs, before/after
n=36
Not specified
2 databases,
1995–2008
COPD
Adult patients with
asthma or COPD
SR and
meta-analysis
Care with 0 or 1 CCM
components
5
6 weeks to 24 months
1. Patient education+case
management
2. Patient education+case
management+professional
education
3. Patient education with
substitution of physician by
nurse
4. Professional and patient
education combined with
pharmacists having an active
role in patient monitoring
Primary, secondary, community
Readmissions:
Group 1 (6 studies): 1 showed
significant reduction
Group 2 (6 studies): 3 showed
significant reduction
Group 3: No differences between
groups
Group 4 (8 studies): Ambiguous
results in all studies.
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Peytremann-Bridevaux
et al (2008);50
Switzerland
RCTs, controlled
before/after n=13
n=8179
5 databases,
inception-2006
COPD
Adult patients
undergoing
disease
management
SR and
meta-analysis
Care without a CCM
component
4
12 months
All included 2+ CCM components;
at least 1 component must have
lasted 12 months.
Delivered by 2+ health
professionals, eg, respiratory
nurse, physiotherapist, GP, practice
nurse, social worker, case
manager, pulmonary care
physician.
Primary, secondary, community
Admissions (10 studies): 7 showed
significant effects in favour of
intervention; 3 found no reduction
in admissions.
Steuten et al (2009);29
Netherlands
Any with data at
two time points
n=20
Not specified
2 databases,
2005–2007
COPD
Mild, moderate,
severe or very
severe COPD
Narrative
Care without a CCM
component
3.5
2–24 months
All included 2+ CCM components.
All included self-management and
delivery system redesign. Several
programmes additionally
encompassed decision support
and/or clinical information systems
Primary, secondary, community
Readmissions: 8/15 studies
reported a reduction in readmission
rates (3 statistically significant).
Relative risk of readmission ranged
from 0.64 to 1.50. Statistically
significant improvements all seen
in studies with 3 or 4 intervention
components. Studies with fewer
components showed no significant
reductions.
Costs (3 studies): Differences
found in individual domains, eg,
higher prescription costs, lower
hospital costs, reduced sick leave
costs. No studies reported
statistically significant findings.
Woltmann et al (2012);51
USA
RCTs n=78
Not specified
6 databases,
inception-2011
Mental health
Adult patients with
mental health
problems
SR and
meta-analysis
Not specified
5
3–36 months
Eligible interventions had to have
at least 3 CCM components.
Primary, secondary, community
Costs (21 studies): 10 reported p
values. 9 of these reported no
difference between intervention
and control groups; 1 favoured
control condition. No statistically
significant findings in any study.
Discharge management
Bettger et al (2012);30
USA
RCTs,
observational,
n=44
Not specified
Stroke, Cardiac
Patients
hospitalised for
stroke/MI
Narrative
Not specified
4
Not specified
1. Hospital-initiated discharge
support
2. Community-based support
models
Readmissions:
Hospital-initiated support: No
impact on readmission rates in 6
studies focusing on stroke; no
impact in 3 studies focusing on MI
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
4 databases,
2000–2012
Provided by nurses, social workers,
OTs, physicians, MDT. Delivered in
person, in home/clinic or by
telephone.
Secondary, community
Community-based support: 1/4
stroke studies found significant
reduction in readmissions; 5/5 MI
studies found statistically
non-significant trends towards
reduced readmission rates
Brady et al (2005);31
Canada
Cost analyses,
economic
evaluations n=15
n=6201
6 databases,
1995–2002
Stroke
Adult patients with
clinical definition of
stroke
Narrative
Standard hospital
discharge and
rehabilitation
4
Up to 12 months
1. Stroke unit care and
rehabilitation with specialised
teams of physicians
2. ESD with organised
interdisciplinary teams to
support patients at home
3. Community rehabilitation via
hospital outpatient clinics or
home-based therapy
Secondary, community
Costs:
Stroke unit care (3 studies): Costs
3% to 11% lower (significant).
ESD (6 studies): Non-significant
trends towards costs of 4% to 30%
lower for patients with mild/
moderate disability. Two lower
quality studies found ESD to cost
more than usual care.
Community rehabilitation (4
studies): 2 reported non-significant
higher costs in intervention; 1
showed no difference, 1 reported
mean direct cost to be 38% lower
than day hospital rehabilitation.
Fearon et al (2012);52 UK RCTs n=14
n=1957
Multiple
databases to 2012
Stroke
Adult patients
admitted to
hospital with stroke
SR and
meta-analysis
Standard discharge
arrangements
5
3–12 months
1. MDT meeting regularly,
coordinated discharge,
postdischarge care and
rehabilitation and care at home
2. As above, but care handed over
to existing community agencies
for support after immediate
postdischarge period
3. Patients access to MDT in
hospital until discharge, then
care provided by community
stroke services
Medical, nursing, physiotherapy,
OT, speech and language
therapists.
Secondary, community
Readmissions (7 studies):
readmission rates similar in
intervention to usual care (31% vs
28%).
LoS (13 studies): Pooled results
showed significant reduction
(p<0.0001). Reduction more
marked in hospital outreach group
than community inreach group but
not statistically significant (p=0.24).
Costs (7 studies): Overall, costs
ranged from 23% less for ESD
group to 15% more compared to
control. No subgroup cost analyses
possible.
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Feltner et al (2014);53
USA
RCTs n=47
Not specified
5 databases,
2007–2013
Heart failure
Adult patients with
moderate to severe
HF
SR and
meta-analysis
Standard discharge
arrangements
4
3–6 months
At least one of:
1. Patient/caregiver education
2. Multidisciplinary HF clinic visits
3. Home visits by nurse or
pharmacist
4. Telemonitoring
5. Structured telephone support
6. Transition coach/case
management
7. Interventions for provider
continuity
Secondary, community
Readmissions:
Home visits (2 studies): Significant
reduction in 30-day all-cause
readmissions (RR 0.34, 95% CI
0.19 to 0.62) and 3–6-month
all-cause readmissions (RR 0.75,
95% CI 0.68 to 0.86).
Significant reduction in 3–6-month
HF-specific readmissions (1 study),
(RR 0.51, 95% CI 0.31 to 0.82).
Multidisciplinary HF clinics (2
studies): Significant reduction in
3 to 6-month all-cause readmission
(RR 0.70, 95% CI 0.55 to 0.89).
No other intervention group had
any significant benefits.
Jeppesen et al (2012);54
Norway, UK, Australia
RCTs n=8
n=870
7 databases,
inception-2010 1
inception-2012
COPD
Adult COPD
patients in ED with
acute exacerbation
SR and
meta-analysis
Standard discharge
arrangements
4.5
6 months
Hospital at home: regular home
visits by a trained respiratory nurse
supported by the hospital team and
telephone support.
Secondary, community
Readmissions (8 studies):
Significant reduction in intervention
group. 9 fewer readmissions per
100 compared to inpatient care
(RR 0.76, 95% CI 0.59 to 0.99,
p=0.04).
Costs (3 studies): 2 reported
significant reduction in direct costs
for intervention; 1 reported
non-significant reduction. Authors
stress low quality of economic
evidence.
Lambrinou et al (2012);55
Greece
RCTs n=19
Not specified
3 databases,
2001–2009
Heart failure
Adult patients with
HF
SR and
meta-analysis
Standard discharge
arrangements
4
3–35 months
Nurse-driven predischarge phase,
incorporating discharge planning or
inpatient education and/or
evaluation.
Telephone follow-up; HF clinic
follow-up; home follow-up or a
combination.
Secondary, community
Readmissions:
All-cause: Significantly reduced
across all interventions (RR 0.85,
95% CI 0.76 to 0.94).
Telephone, HF clinic, combined
settings all non-significant.
Home follow-up: RR 0.80 (95% CI
0.70 to 0.91).
HF-specific: Significantly reduced
across all interventions (RR 0.68,
95% CI 0.53 to 0.86).
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Telephone follow-up (RR 0.65,
95% CI 0.43 to 1.00)
HF clinic: Non-significant.
Home follow-up: RR 0.51 (95% CI
0.33 to 0.79)
Combined settings: RR 0.58 (95%
CI 0.45 to 0.73).
Langhorne et al (2005);56
UK
RCTs n=11
n=1597
Databases not
specified
Stroke
Inpatients with
clinical diagnosis
of stroke
SR and
meta-analysis
Standard hospital
discharge and
rehabilitation
5
3–12 months
1. ESD team coordination and
delivery; MDT coordinate
discharge and postdischarge
care and rehabilitation at home
2. ESD team coordination;
postdischarge care by
community agencies
3. No ESD team; MDT care in
hospital, postdischarge care by
uncoordinated community
services/healthcare volunteers
Medical staff, nurses,
physiotherapy, therapists, assistant
staff, social workers
Secondary, community
Readmissions (5 studies): similar
rates between intervention and
control (27% vs 25%; OR 1.14,
95% CI 0.80 to 1.63).
LoS (9 studies): Overall, significant
reduction in intervention of 7.7 days
(95% CI 4.2 to 10.7).
Reduction greater for hospital
outreach than community inreach
(15 days, 95% CI 9 to 22 vs
5 days, 95% CI 1 to 9).
Controlling for stroke severity,
greater reduction in severe vs
moderate group (28 days, 95% CI
15 to 41 vs 4, 95% CI 2 to 6).
Costs (5 studies): Intervention
costs lower than control (range 4%
to 30% lower; median reduction
20%). Significance not stated.
McMartin (2013);57
Canada
RCTs, SR,
meta-analysis
n=11
Not specified
6 databases,
2004–2011
Chronic disease
Adults with chronic
diseases
SR and
meta-analysis
Standard discharge
arrangements
3
Not specified
1. Discharge planning vs usual
care
2. Comprehensive discharge
planning with postdischarge
support vs usual care, where
postdischarge support could
include home visits, telephone
follow-up.
Secondary, community
Readmissions:
Discharge planning (11 studies):
Moderate evidence that
intervention is effective (RR 0.85,
95% CI 0.74 to 0.97).
Discharge planning+postdischarge
support: low quality evidence that
this is more effective than
discharge planning alone.
LoS: Discharge planning more
effective than usual care (mean
reduction of 0.91 days, 95% CI
1.55 to 0.27). Discharge planning
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
plus postdischarge support not
more effective than discharge
planning alone (mean reduction
0.37 days (95% CI 0.15 to 0.60).
Olson et al (2011);32 USA
RCTs,
observational,
registries n=62
Not specified
4 databases,
2001–2011
Stroke, cardiac
Adults discharged
after acute stroke
or MI
Narrative
No transitional care
across multiple
providers
3.5
12 months
1. Hospital-initiated discharge
support
2. Community-based support
models
3. Chronic disease management
models
4. Patient education, goal-setting
Nurses, social workers, OTs,
physicians, MDT to facilitate
transition from hospital to home. In
person, home/clinic or telephone.
Secondary, community
Readmissions:
Hospital-initiated support:
(8 studies): 4 studies reported
reduced readmission rates;
4 reported no difference between
groups.
No other intervention type showed
any significant difference between
groups.
Phillips et al (2004);58
USA
RCTs n=19
Not specified
7 databases,
inception-2003
Heart failure
Older patients with
congestive heart
failure
SR and
meta-analysis
Standard discharge
arrangements
5
3–12 months
Postdischarge support as:
1. Single home visit for HF
education
2. Increased clinic follow-up
3. Frequent telephone contact for
education, self-care,
appointments
4. Extended multidisciplinary
home care
5. Day hospital service in
specialist HF unit
Secondary, community
Readmissions:
Group 1 (3 studies): 41%
intervention, 53% control.
Significant.
(RR 0.76, 95% CI 0.63 to 0.93).
Group 2 (4 studies): 41%
intervention, 41% control.
Non-significant. (RR 0.64, 95% CI
0.32 to 1.28).
Group 3 (6 studies): 38%
intervention, 49% control.
Significant.
(RR 0.79, 95% CI 0.69 to 0.91).
Group 4 (4 studies): 30%
intervention, 36% control.
Non-significant.
Group 5 (1 study): 7% intervention,
33% control. Significant.
(RR 0.25, 95% CI 0.21 to 0.44).
LoS (10 studies): Pooled analysis
showed no significant difference
between groups (mean days
8.4 vs 8.5, p=0.60).
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Costs (8 studies): 4 US based
studies found significant costs
reductions per patient per month of
US$536 (95% CI −US$956 to −US
$115). 4 non-US studies found no
significant cost differences.
Phillips et al (2005);59
USA
RCTs n=7
n=949
5 databases,
inception-2004
Heart failure
Adult patients with
heart failure
SR and
meta-analysis
Not specified
4
3–12 months
Specialist nurse-led clinics to
manage discharge transitions.
Categorised by:
1. Complex interventions:
discharge planning,
postdischarge follow-up, no
delay in continuity after
discharge (3 studies)
2. Less complex: no discharge
planning and/or fewer
components (4 studies)
Secondary, community
Readmissions:
All-cause: ‘Complex’ programmes
non-significant (RR 0.30, 95% CI
0.04 to 2.60). ‘Less complex’
non-significant (RR 1.00, 95% CI
0.86 to 1.17).
HF-specific: ‘Complex’
programmes significant reduction
(RR 0.09, 95% CI 0.10 to 0.65.
‘Less complex’ significant reduction
(RR 0.65, 955 CI 0.43 to 1.00).
LoS: Complex interventions
reduced LoS by 0.26 days
compared to usual care
(non-significant). Less complex
interventions reduced LoS by
0.09 days (non-significant).
Costs: Only reported for complex
interventions. 3 studies showed
non-significant potential savings of
US$277 per patient per month.
Prieto-Centurion (2014);33
USA
RCTs n=5
n=1393
4 databases,
inception-2013
COPD
Exacerbation in
previous
12 months
Narrative
Not specified
3
6 or 12 months
Predischarge, postdischarge or
bridging interventions across both
periods.
Education, health counselling,
action plans delivered via
telephone, home visits or
consultation with primary care
providers
Primary, secondary, community
Readmissions:
All-cause: 2/5 studies showed
significant reduction at 12 months:
45% vs 67% hospitalised
(p=0.028).
COPD-specific: 1/5 studies showed
significant reduction at 12 months:
32% vs 50% hospitalised (p=0.01).
Interventions grouped according to: Costs:
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Tummers et al (2012);34
Netherlands
RCTs, CCTs,
n=15
n=3536
2 databases,
inception-2011
Stroke
Adult patients who
had stroke
Narrative
Standard hospital
discharge and
rehabilitation
3
3–12 months
1. ESD by MDT, home-based
rehabilitation
2. Stroke unit care with MDTs to
reach rehabilitation goals before
discharge
3. Stroke service via network of
providers organising services in
all follow-up stages
Primary, secondary, community
Group 1 (4 studies): 3 reported
non-significant increases in
intervention; 1 reported no
difference between groups.
Group 2 (2 studies): Both found
stroke units to be more expensive
than conventional care (borderline
significance).
Group 3 (3 studies): 2 reported a
cost reduction in intervention
group.
Winkel et al (2008);35
Denmark, Sweden
RCTs n=17
n=1122
5 databases,
inception-2005
Stroke
Adult patients who
had been living at
home before a
stroke
Narrative
Standard discharge
arrangements
4
1–12 months
Delivered by MDTs which all
included physiotherapists and OTs.
Some also included nurse, social
worker, GP and other specialist
expertise, eg, geriatrician.
1. ESD with hospital teams
providing home rehabilitation
after discharge
2. ESD with no direct rehabilitation
from hospital teams
3. Community-based rehabilitation
after discharge
Primary, secondary, community
Readmissions:
Group 1 (3 studies): No difference
between groups.
Group 2 (2 studies): No difference
between groups.
Group 3 (1 study): No difference
between groups.
Costs:
Group 1 (2 studies): Intervention
costs significantly lower than
control at 3 and 12 months.
Group 2 (1 study): ‘Some’ evidence
that intervention costs are lower
than control in 12 months after
stroke.
Group 3 (1 study): Costs for the
most independent patients were
lowest when rehabilitated in
hospital rather than home.
Interventions most cost-effective
when delivered by hospital MDT.
Yu et al (2006);36 Hong
Kong
RCTs n=21
n=4445
3 databases,
1995–2005
Heart Failure
Adult patients with
heart failure
Narrative
Not specified
4
3–50 months
Postdischarge interventions
delivered via home visits, HF clinic
visits and/or telephone.
Interventions comprised
multidisciplinary care, case
management and structured
discharge planning and all included
Readmissions: 11 ‘effective’
programmes had significant
reductions ranging from 29% to
85%. 10 others demonstrated no
significant changes. Effective
programmes included an
in-hospital phase, patient
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Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
patient education and/or
self-management
Primary, secondary, community
education, self-care, surveillance
and deterioration management.
Involvement of cardiac nurses and
cardiologists associated with
increased likelihood of successful
intervention.
Costs: 8 ‘effective’ programmes did
cost analysis, 7 of which showed a
cost saving for the intervention
over usual care.
Complex interventions
Dickens et al (2014);60
UK
RCTs n=32
n=3941
5 databases,
inception-2013
COPD
Adult patients with
COPD
SR and
meta-analysis
Not specified
4
1–24 months
Multiple components and/or
multiple professionals, given
individually or in groups, or using
technology.
Could include education,
rehabilitation, psychological
therapy, social or organisational
interventions. Delivered at home, in
community, hospital or doctor clinic
or combination of these.
Primary, secondary, community
A&E use: Pooled effects showed
interventions associated with 32%
reduction (OR 0.68, 95% CI 0.57 to
0.80). Subgroups:
General education (28 studies): OR
0.66, 95% CI 0.55 to 0.81.
Exercise (11 studies): OR 0.60,
95% CI 0.48 to 0.76.
Relaxation (4 studies): OR 0.48,
95% CI 0.33 to 0.70.
Non-significant trends for
interventions including skills
training (p=0.35, 13 studies),
relapse prevention (p=0.12, 11
studies).
Martinez-González et al
(2014);70 Switzerland
SR,
meta-analyses
n=27
Not specified
4 databases,
inception-2012
Chronic disease
Adult patients with
chronic diseases
Review of reviews
Not specified
3
Not specified
Included any interventions based
on disease management, case
management, managed care,
comprehensive care,
multidisciplinary care, coordinated
care, team care, CCMs.
Primary, secondary, community
Admissions: 10/17 reviews
demonstrated reduced admissions
Readmissions: 7/12 reviews
demonstrated reduced
readmissions
LoS: 9/13 reviews demonstrated
shorter length of stay
A&E use: 6/11 reviews showed
reduced rates of ED visits
Costs: 3/17 reviews demonstrated
cost reductions
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Study types, n;
participants n;
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review type
Comparator; QA
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Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Takeda et al (2012);61 UK RCTs n=25
n=5942
10 databases,
inception to 2009
Heart failure
Adults with at least
one HF secondary
care admission
SR and
meta-analysis
Not specified
5
6–24 months
All led by professionals from
secondary or tertiary care.
Interventions grouped as:
1. Case management, telephone
and home visits
2. Specialist nurse-led HF clinics
3. Multidisciplinary interventions to
bridge the gap between acute
and home settings
Secondary, community
Readmissions:
HF-specific (12 studies): Overall,
significantly reduced (OR 0.57,
95% CI 0.43 to 0.75, p<0.0001).
Subgroups:
Group 1: Significant reduction at
6 months (3 studies) and
12 months (7 studies). OR 0.64
(95% CI 0.46 to 0.88) and OR 0.47
(95% CI 0.30 to 0.76), respectively.
Group 2: No difference between
groups.
Group 3 (2 studies): Significant
reduction OR 0.45, 95% CI 0.28 to
0.72). All-cause also significantly
reduced with multidisciplinary
interventions: (OR 0.46, 95% CI
0.30 to 0.69).
Multidisciplinary teams
Health Quality Ontario
(2012);71 Canada
SR and
meta-analyses
n=24
Not specified
6 databases,
2008–2011
Heart failure,
COPD
Adult patients with
heart failure or
COPD
Review of reviews
Usual care in general
practice
3
Not specified
Interventions to provide formalised
links between primary and
specialist care via disease-specific
education, medication review,
physical activity and lifestyle
counselling, self-care and
follow-up. Delivered by
intermediate care teams including
GPs, specialists, nurses, social
workers, pharmacists, dieticians.
Primary, secondary, community
Admissions:
All-cause (7 studies).
Non-significant 4% RR reduction
after 1 year (low quality).
COPD-specific (4 studies).
Significant 25% RR reduction after
1 year (moderate quality).
HF-specific (6 studies).
Non-significant 14% RR reduction
after 1 year (low quality).
Health Quality Ontario
(2013);37 Canada
SR, RCTs,
observational
studies n=20
Not specified
5 databases,
2002–2011
Chronic disease
Adult patients with
one or more
chronic diseases
Narrative
Not specified
3
Not specified
Informational, management and
relational continuity. Assessed by:
1. Duration (length of relationship)
2. Density (number of visits with
same provider in a set period)
3. Dispersion (visits with distinct
providers)
4. Sequence (order of seeing
providers).
Primary, community
Admissions:
Three studies. None reported any
significant differences between
intervention and control groups
(low quality).
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Holland et al (2005);62 UK RCTs n=30
n=815813
databases
inception-2004
Heart failure
Adult patients with
congestive heart
failure
SR and
meta-analysis
Not specified
5
Not specified
Interventions with management by
an MDT that included medical input
plus one or more of specialist
nurse, pharmacist, health educator,
dietician or social worker:
1. Education/self-management
home visits
2. Telephone follow-up only
3. Intervention during hospital
admission or hospital clinic
attendance
Primary, secondary, community
Admissions:
All-cause (21 studies): Significant
reduction in intervention (RR 0.87,
95% CI 0.79 to 0.95, p=0.002).
Significant heterogeneity.
HF-specific (16 studies): Significant
reduction in intervention (RR 0.70,
95% CI 0.61 to 0.81, p<0.0001).
LoS (10 studies): Significant
reduction in mean inpatient days of
1.9 in intervention (95% CI 0.71 to
3.1).
Home-based interventions reduced
mean days in hospital.
Interventions solely delivered in
hospital, clinic or primary care
showed no significant benefits.
Koshman et al (2008);63
Canada
RCTs n=12
n=2060
10 databases
inception-2007
Heart failure
Adult patients with
heart failure
SR and
meta-analysis
Heart failure care
without pharmacist
involvement
4
6–12 months
Pharmacists providing HF and
medication education through
self-monitoring support, compliance
facilitation.
Either via directed care where
pharmacist is the key driver, or
collaborative care with pharmacist
as part of MDT.
Secondary, community
Admissions:
All-cause (11 studies): Significant
reduction (OR 0.71, 95% CI 0.54 to
0.94). No difference between
directed and collaborative care
model.
HF-specific (11 studies): Significant
reduction (OR 0.69, 95% CI 0.51 to
0.94). Collaborative care model
associated with greater reduction in
HF-specific admission than
directed care (OR 0.42, 95% CI
0.24 to 0.74 vs OR 0.89, 95% CI
0.68 to 1.17, p=0.02).
McAlister (2004);64 UK RCTs n=29
n=5039
7 databases,
inception-2003
Heart failure
Adult patients with
HFSR and
meta-analysis
Not specified
4
1–12 months
1. Multidisciplinary HF clinic
2. MDT providing specialised
follow-up outside hospital
3. Telephone follow-up with
primary care attendance in the
event of deterioration
4. Self-care education
5. Primary, community
Admissions:
Groups 1+2: HF hospitalisation
significantly reduced (RR 0.74,
95% CI 0.63 to 0.87); all-cause
hospitalisation significantly reduced
(RR 0.81, 95% CI 0.71 to 0.92).
Group 3: HF hospitalisation
significantly reduced (RR 0.66,
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
95% CI 0.52 to 0.83). All-cause
hospitalisation no significant effect.
Group 4: HF hospitalisation
significantly reduced (RR 0.66,
95% CI 0.52 to 0.83). All-cause
hospitalisation significantly reduced
(RR 0.73, 95% CI 0.57 to 0.93).
Costs (18 studies): 15 found cost
savings; 3 found neutral costs.
Medical Advisory
Secretariat (2009);65
Canada
RCTs n=8
n=2692
4 databases,
inception-2008
Heart failure
Adult patients with
HF
SR and
meta-analysis
Care not provided by
multiple practitioners
4
At least 12 months
All included a team of nurse and
physician and/or general
practitioner, one of which
specialised in HF management.
Varying combinations of
disease-specific education, diet,
lifestyle, exercise counselling,
self-care support, follow-up.
Delivered directly (clinic based
programme) or indirectly (telephone
based, physician supervised,
nurse-led).
Primary, secondary, community
Readmissions:
All-cause (7 studies):
Non-significant increase in
intervention group. Significant 12%
reduction when care delivered
through a direct (clinic) model.
HF-specific (6 studies):
Non-significant RR reduction of
14% in intervention.
LoS (7 studies): Patients receiving
intervention generally had shorter
LoS whether measured as mean
duration (4 studies) or total bed
days (3 studies).
A&E use (1 study): 77% of
intervention patients vs 84% of
control patients had an ED visit
within 12 months (p=0.029).
Roccaforte et al (2005);66
Canada
RCTs n=33
Not specified
4 databases,
1980–2004
Heart failure
HF patients
followed up in
outpatient setting
SR and
meta-analysis
Referral to family
physician or home care
services after discharge
5
3–22 months
1. Multidisciplinary approach,
starting during hospitalisation,
continuing for up to 12 months
postdischarge, delivered by
various professionals
2. Approach centred on specific
health professionals, eg, HF
specialist nurses or case
managers, focused on
particular care components, eg,
therapy adherence
Primary, secondary, community
Readmissions:
All-cause: 7/32 studies found
significant reductions (OR 0.76,
95% CI 0.69 to 0.94).
HR-specific: 8/20 found significant
reductions (OR 0.58, 95% CI 0.50
to 0.67). By subgroup:
Group 1: All-cause and HF-specific
readmissions significantly reduced
(OR 0.58, 95% CI 0.47 to 0.71)
and (OR 0.58, 95% CI 0.45 to
0.75), respectively.
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Group 2: All-cause and HF-specific
readmissions significantly reduced
(OR 0.82, 95% CI 0.74 to 0.91)
and ()R 0.61, 95% CI 0.51 to 0.73),
respectively.
LoS (12 studies): Significant
reduction of −1.49 days (95% CI
−2.03 to −0.95 days).
Sikich (2012);38 Canada HTAs, SR, RCTs,
n=6
n=1370
6 databases,
1995–2010
COPD
Adult patients with
COPD
Narrative
Care not provided by
multiple practitioners
4
3–12 months
Interventions based on CCM
components, delivered by various
professionals as a team in one
organisation or range of
organisations together as a unique
team.
Most teams included a respiratory
specialist and/or a physician.
Primary, secondary, community
Admissions:
All-cause (4 studies): Statistically
significant 25% RR reduction in
favour of intervention (p<0.0001)
(moderate evidence).
COPD-specific (3 studies):
Statistically significant 33% RR
reduction in favour of intervention
(p=0.002) (moderate evidence).
A&E use:
All-cause (2 studies): Both showed
non-significant reduction (RR 0.64,
95% CI 0.31 to 1.33).
COPD-specific (1 study):
Significant reduction (RR 0.59,
95% CI 0.43 to 0.81).
Smith et al (2007);39
Ireland
RCTs, CCTs,
before/after, time
series n=20
Not specified
7 databases,
inception-2006
Chronic disease
Patients in a
primary and
secondary shared
care service
Narrative
Care not provided by
multiple practitioners
5
Not specified
Liaison meetings attended by
specialists and primary care staff to
discuss and plan ongoing patient
management; shared care record
carried by the patient,
computer-assisted shared care and
email with data available to primary
and secondary care
Primary, secondary
Admissions (7 studies): Mixed
results. Intervention was
associated with a reduction in
admissions in older patients and
those with higher baseline
morbidity.
Costs (11 studies): 3 performed full
economic analyses, of which 2
reported incremental cost savings
in intervention. Seven studies
reported direct costs: 1 showed
higher costs in intervention; 6
reported mixed results (4/6 showed
intervention more expensive than
control, 2/6 reported lower costs in
intervention).
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Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
Condition(s);
population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
Smith et al (2012);40
Ireland*
RCTs, CCTs,
before/after, time
series
n=10
n=3357
9 databases,
various–2011
Chronic disease
Patients with
multimorbidity in
primary care or
community
Narrative
Not specified
5
2–24 months
Any intervention to improve
outcomes for patients with
multimorbidity in primary or
community care delivered by an
MDT.
6 studies assessed MDT
interventions.
Primary, community
Admissions (5 studies): One study
found significant reduction in
admissions with intervention; 4
found no difference between
groups.
Costs (4 studies): One reported no
difference between groups; one
had no results available; one
reported a non-significant marginal
benefit for intervention, one
reported net savings in intervention
costs but did not account for other
costs.
Self-management
Franek (2013);41 Canada SR, RCTs,
meta-analyses
n=10
n=6074
5 databases,
2000–2012
Chronic disease
Adult patients with
chronic disease
Narrative
Care from the usual
provider
3.5
4–12 months
Stanford chronic disease
programme: 6 weekly 2.5 hour
sessions with 10–15 participants,
in community settings, with
volunteer lay facilitators assisting
patients to make their own
management choices and reach
self-selected goals.
Primary, secondary, community
Admissions (3 studies): No
significant difference in admission
rates between intervention and
control in any study (low quality
evidence).
LoS (5 studies): None showed any
significant differences between
groups at 6 months.
A&E use (5 studies): No significant
differences between groups.
Harrison et al (2015);67
Canada
RCTs n=7
n=1115
7 databases,
inception-2014
COPD
Adult patients
hospitalised
following acute
exacerbation
SR and
meta-analysis
Not specified
3.5
2 weeks-12 months
Action plans involving symptom
monitoring, education and at least
2 of 7 self-management skills
(self-efficacy, problem solving,
resource use, collaboration,
emotional/role management, goal
setting).
Delivered by nurses when patient
is in hospital, or within 1 month of
discharge.
Secondary, community
Readmissions (5 studies).
Meta-analysis found no significant
differences at 12 months between
intervention and control groups in
terms of the number of patients
readmitted to hospital. Mean
difference 1.32, CI 0.71 to 2.46
(p=0.38).
Jovicic et al (2006);42
Canada
RCTs n=6
n=857
Heart failure
Adult patients with
Not specified
4
3–12 months
Education and limited follow-up:
patients taught to monitor condition
and recognise symptom
Readmissions:
Continued
O
p
e
n
A
c
c
e
s
s
22
Dam
ery
S,etal.BM
J
Open
2016;6:e011952.doi:10.1136/bm
jopen-2016-011952
group.bmj.com
 o
n
 N
ovem
ber 22, 2016 - Published by 
http://bmjopen.bmj.com/
D
ow
nloaded from
 
Table 2 Continued
Author (year); country
Study types, n;
participants n;
databases
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population(s);
review type
Comparator; QA
score; time scale
Intervention summary; health/
social care settings
Findings of review by outcome
(intervention vs control)
6 databases,
inception-2005
HF
Narrative
exacerbation; follow-up phone call
and face to face or digital
education.
Delivered by nurses or AHPs.
Secondary, community
All-cause (5 studies): Significant
reduction in intervention (OR 0.59,
95% CI 0.44 to 0.80).
HF-specific (3 studies): Significant
reduction in intervention (OR 0.44,
95% CI 0.27 to 0.71).
Costs (3 studies): All reported
annual savings for intervention vs
usual care of between US$1300
and US$7515.
Smith et al (2012);40
Ireland
RCTs, CCTs,
before/after, time
series
n=10
n=3357
9 databases,
various–2011
Chronic disease
Patients with
multimorbidity in
primary care or
community
Narrative
Not specified
5 2–24 months
Any patient-orientated intervention
to promote self-management in
patients with multimorbidity in
primary or community care.
Four studies assessed
self-management interventions.
Primary, community
Admissions (2 studies): One
reported significant reduction in
favour of intervention. The other
found no difference between
groups.
Costs (2 studies): One reported
cost savings per participant due to
reduction in admission rates in
intervention group. The other found
no difference between groups.
Zwerink et al (2014);68
Netherlands
RCTs, controlled
trials, n=31
n=3688
6 databases,
1995–2011
COPD
Patients with
clinical diagnosis
of COPD
SR and
meta-analysis
Not specified
5
2–24 months
Structured interventions to improve
self-health and self-management
skills.
At least 2 of action plan, exercise
programme, smoking cessation,
dietary advice, medication review,
coping with breathlessness advice,
CBT, motivational interviewing,
goal setting, feedback.
Primary, secondary, community
Admissions:
All-cause (6 studies): 310 patients
per 1000 admitted within
12 months in intervention vs 428
control. Statistically significant
reduction (OR 0.60, 95% CI 0.40 to
0.89).
COPD-specific (9 studies): 190
patients per 1000 admitted within
12 months in intervention vs 293
control. Statistically significant
reduction (OR 0.57, 95% CI 0.43 to
0.75).
LoS (5 studies): No differences
between groups.
*Smith et al40 listed twice due to focus on MDT interventions and self-management interventions.
AHP, allied health professional; CBT, cognitive–behavioural therapy; CCM, chronic care model; CCT, controlled clinical trial; ED, emergency department; ESD, early supported discharge; HF,
heart failure; HTA, health technology assessment; LoS, length of stay; MDT, multidisciplinary team; MI, myocardial infarction; OT, occupational therapy; QA, quality assessment; RR, relative risk;
SMD, standardised mean difference; SR, systematic review.
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association between the intervention and outcomes
assessed. Of nine reviews focusing on interventions
comprising one or more components of the CCM,
six reported positive ﬁndings for at least one
outcome.28 46–48 50 69 All CCM reviews reported that
interventions with multiple components were signiﬁ-
cantly more effective than single component interven-
tions at reducing admission rates,46 49 50 69 with
reductions of 22–32% observed in reviews that
performed meta-analysis. Multicomponent interventions
were also successful in reducing readmissions by
15–30%,47 length of hospital stay by 2–4 days46 48 and
A&E visits by 42%.46
Fifteen reviews assessed discharge management inter-
ventions, predominantly focusing on readmission rates
and length of stay (LoS). Six reviews reported signiﬁcant
reductions in readmission rates for patients with heart
failure,53 55 58 59 COPD54 and general chronic diseases.57
Reductions ranged from 15%55 to 66%.53 In contrast,
discharge management for patients who had stroke
was notably ineffective in reducing readmission
rates,32 35 52 56 although LoS reduced by 7.7 days in one
stroke review.56 Three reviews assessed complex interven-
tions. One demonstrated a 32% reduction in A&E use,60
another reported a 43% reduction in heart
failure-related readmissions61 and a review of reviews
reported positive ﬁndings for admissions, readmissions,
LoS and A&E use (no effect sizes given).70
Ten reviews assessed MDT interventions. Although
team composition varied, MDT were generally
effective when used for patients with single conditions,
showing a 26–31% reduction in admission rates for
heart failure62–64 and a 33% RRR for admissions in
patients with COPD.38 MDT were also associated with a
42% reduction in heart failure readmissions,66 a 2-day
reduction in LoS,62 65 66 signiﬁcantly reduced A&E use65
and signiﬁcantly lower healthcare costs.64 Conversely,
MDT for general chronic disease management showed
mixed effectiveness or no signiﬁcant association for any
outcomes,37 39 40 suggesting that the crucial component
of an effective MDT is the inclusion of condition-speciﬁc
specialist expertise in the team skill mix. Finally, ﬁve
reviews assessed self-management interventions. Three
showed either mixed ﬁndings40 or no association
between intervention and outcomes assessed.41 67 The
remaining two demonstrated signiﬁcant reductions in
readmission rates and healthcare costs for patients with
heart failure42 and signiﬁcantly lower admission rates for
COPD.68
Hospital admissions
Emergency admission rates were assessed in 21 reviews
across ﬁve intervention categories (table 4). Eleven
reviews reported signiﬁcantly reduced admis-
sions,38 45 46 48 50 62–64 68–70 with all but two positive
reviews focusing on heart failure45 62–64 or
Table 3 Intervention groupings
Category Description of intervention
Case management
(n=8)23–27 43–45
Based on implementation of a collaborative process between one or more care
coordinators or case managers and the patient, to assess, plan and facilitate service
delivery for patients with chronic diseases, particularly when transitions across healthcare
settings are required
Chronic care model
(n=9)28 29 46–51 69
Model that identifies six modifiable elements of healthcare systems: (1) organisational
support, addressing organisational culture and leadership, (2) clinical information systems
to organise patient, population and provider data, (3) delivery system design to address
composition and function of the care team and follow-up management, (4) decision
support to increase provider access to evidence-based guidelines and specialists for
collaboration, (5) self-management support to provide tailored education, skills training,
psychosocial support and goal-setting and (6) community resources to provide peer
support, care coordination and community-based interventions
Discharge management
(n=15)30–36 52–59
Interventions designed to facilitate effective transitions from hospital care to other settings.
Typically includes a predischarge phase of support, transitional care for the move
between the hospital and community/home setting and postdischarge follow-up and
monitoring, often incorporating rehabilitation or reablement support
Complex interventions
(n=3)60 61 70
Two reviews assessed a range of interventions rather than focusing on a single
intervention or service model
Multidisciplinary teams
(n=10)37–40 62–66 71
Interventions comprising teams composed of multiple health and/or social care
professionals working together to provide care for people with complex needs. Teams
typically included condition-specific expertise, nurses, occupational therapists,
physiotherapists, social workers, GPs and occasionally pharmacists or case managers
Self-management
(n=5)40–42 67 68
Interventions designed to provide patient support, typically via tailored education to inform
the patient about their condition(s), recognising signs and symptoms of disease
exacerbation, dietary and lifestyle advice and/or condition-specific education supporting
medication adherence
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Table 4 Summary of effectiveness for each outcome by review and intervention category
Review Admissions Readmissions Length of stay A&E use Costs
Case management
Hickam et al (2013)23 ? ?
Hutt et al (2004)24 ? ? ? ?
Latour et al (2007)25 ? ? =
Manderson et al (2012)26 –
Oeseburg et al (2009)27 ? ? ? ?
Stokes et al (2015)43 =
Taylor et al (2005)44 ?
Thomas et al (2013)45 –
Chronic care model
Adams et al (2007)46 – – – –
de Bruin et al (2012)28 ? –
Gonseth et al (2004)47 – –
Hisashige (2013)69 – ?
Kruis et al (2013)48 – –
Lemmens et al (2009)49 ?
Peytremann-Bridevaux et al (2008)50 –
Steuten et al (2009)29 ? =
Woltmann et al (2012)51 =
Discharge management
Bettger et al (2012)30 ?
Brady et al (2005)31 ?
Fearon et al (2012)52 = – ?
Feltner et al (2014)53 –
Jeppesen et al (2012)54 – –
Lambrinou et al (2012)55 –
Langhorne et al (2005)56 = – ?
McMartin (2013)57 – –
Olson et al (2011)32 =
Phillips et al (2004)58 – = –
Phillips et al (2005)59 – = =
Prieto-Centurion et al (2014)33 ?
Tummers et al (2012)34 ?
Winkel et al (2008)35 = –
Yu et al (2006)36 ? –
Complex interventions
Dickens et al (2014)60 –
Martinez-Gonzelez et al (2014)70 – – – – ?
Takeda et al (2012)61 –
Multidisciplinary teams
Health Quality Ontario (2012)71 –
Health Quality Ontario (2013)37 –
Holland et al (2005)62 – – –
Koshman et al (2008)63 ? –
McAlister et al (2004)64 ?
Medical Advisory Secretariat (2009)65 = –
Roccaforte et al (2005)66 – –
Sikich (2012)38 – ?
Smith et al (2007)39 ? ?
*Smith et al (2012)40 ? ?
Self-management
Franek (2013)41 = = =
Harrison et al (2015)67 =
Jovicic et al (2006)42 – –
Smith et al (2012)40 ? ?
Zwerink et al (2014)68 – =
*Smith et al (2012) listed twice due to focus on MDT interventions and self-management interventions.
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COPD.38 46 48 50 68 The most effective interventions were
based on the CCM, for which 4/5 reviews showed statis-
tically signiﬁcant reductions in admission rates following
the intervention. Multiple component strategies were
associated with reductions of between 22%46 and 32%48
in admission rates for patients with COPD.
MDT interventions were also effective, with 4/8 reviews
showing signiﬁcant reductions in admissions. Effect sizes
ranged from 25% for a COPD MDT with formal links to
primary care,38 through 26% for teams that included spe-
cialist heart failure expertise,64 to 31% for teams that
included pharmacists as collaborators.63 One review of
structured self-management interventions demonstrated a
43% reduction in the relative risk of COPD-related admis-
sion.68 Case management interventions were largely inef-
fective in reducing admission rates, with 3/4 showing
mixed ﬁndings,23 24 27 although one case management
intervention for heart failure comprising intensive
follow-up that gradually reduced in intensity over time
showed a potential 58% reduction in admissions.45
Most reviews reported condition-speciﬁc admissions and
admissions for any cause. In all cases, potential reductions
in condition-speciﬁc admissions were substantially greater
than those for all-cause admissions.38 45 62–64 68
Hospital readmissions
Twenty-four reviews assessed readmissions. Eleven
reported positive ﬁndings: eight for heart
failure,42 47 53 55 58 59 61 66 two for chronic disease57 70
and one for COPD.54 Discharge management was the
most effective intervention, with 6/13 reviews showing
signiﬁcant reductions in readmission rates.53–55 57–59
Interventions incorporating an inpatient phase and post-
discharge support at home were associated with reduc-
tions in condition-speciﬁc readmission rates of 24%32
and 49%53 for heart failure interventions, 24% for a hos-
pital at home intervention for COPD54 and a 15%
reduction for patients with chronic diseases.57 Similarly,
‘complex’ interventions that included specialist
nurse-led clinics for heart failure follow-up were asso-
ciated with a 91% reduction in condition-speciﬁc
readmission rates in one review,59 and postdischarge hos-
pital outreach coordinated by a MDT was associated with
a 32% reduction in heart failure readmission rates.55 In
contrast, discharge interventions for patients who had
stroke were ineffective, with 0/4 reviews assessing this
intervention showing no differences between interven-
tion and control groups.32 35 52 56
Other interventions showed less comprehensive evi-
dence. One of three CCM reviews that assessed readmis-
sions found a 30% reduction in readmission rates for
heart failure.47 One self-management review in which
nurses provided heart failure-speciﬁc education reported
a 56% reduction in readmissions.42 Two reviews assessing
complex interventions reported signiﬁcant reductions in
readmission rates: one for a heart failure case manage-
ment intervention61 and another for patients with
general chronic diseases.70 One MDT review showed a
42% reduction in heart-failure speciﬁc readmission, with
subgroup analysis indicating that heart failure specialist
nurses could reduce condition-speciﬁc readmissions by
up to 39%.66
As with admissions, potential reductions in readmis-
sions were substantially greater for condition-speciﬁc
readmissions than all-cause readmissions, with effect
sizes in the former typically double those for the
latter.47 53 56 66
Length of stay
Sixteen reviews assessed LoS, across six intervention cat-
egories. Neither case management interventions24 25 27
or self-management interventions41 68 showed evidence
of effectiveness, but there were positive ﬁndings in the
CCM,46 48 discharge management,52 56 57 complex inter-
vention60 and MDT groups.62 65 66 Two CCM interven-
tions were associated with a signiﬁcantly reduced mean
LoS for COPD of 2.5146 and 3.78 days, respectively.48
Three discharge management reviews showed signiﬁ-
cant LoS reductions. Two were for patients who had
stroke, including postdischarge support coordinated
through multidisciplinary hospital outreach52 and early
supported discharge.56 Pooled results from the early sup-
ported discharge meta-analysis suggested a mean LoS
reduction of 7.7 days, rising to 28 days for the most
severely impaired patients compared to 4 days for mod-
erately impaired patients.56 One discharge management
intervention for patients with chronic diseases reported
positive results, with a modest reduction of 0.91 days.57
Finally, three MDT interventions showed signiﬁcant
reductions in LoS, all for heart failure patients. Again,
reductions were modest at 1.9 days for an MDT that
included a clinician plus specialist nurse, pharmacy,
health education, dietician and social worker support,62
a ‘generally shorter’ LoS for an intervention based on
nurses, heart failure physicians and general practitioners
(GPs) providing condition-speciﬁc patient education65
and a MDT providing hospital outreach for at least
12 months after hospital discharge was associated with a
mean reduction in LoS of 1.49 days.66
Accident and emergency use
Nine reviews measured the effectiveness of interventions
in reducing Accident and Emergency (A&E) use. Five
reviews included patients with chronic diseases, all
showing mixed ﬁndings or no association between inter-
vention and outcome.24 25 27 41 70 The remaining
reviews assessed single conditions, with 2/3 demonstrat-
ing statistically signiﬁcant reductions in A&E use for
COPD,46 60 and one showing signiﬁcant ﬁndings in
patients with heart failure.65
Case management and self-management interventions
were ineffective in reducing A&E use.24 25 27 41 Effective
interventions related to the CCM, where multicompo-
nent COPD interventions were associated with a 42%
reduction in A&E use,46 the complex intervention
group, where interventions with multiple components
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administered by multiple professionals demonstrated a
potential 32% reduction in A&E use,60 and the MDT
group, where one review found a signiﬁcant reduction
in A&E use when an MDT for heart failure contained
condition-speciﬁc specialist expertise.65 However, A&E
use remained high overall, with 77% of patients in the
intervention group having at least one emergency
department visit during the 12-month follow-up period,
compared to 84% of control patients.
Costs
Twenty-ﬁve reviews assessed healthcare costs but the evi-
dence base was poor and heterogeneous—information
on potential cost savings was typically qualitative and
could not be compared across reviews. Ten reviews
reported positive ﬁndings: ﬁve for patients with heart
failure,36 42 47 58 64 two for COPD,46 54 two for chronic
disease26 28 and one for stroke.35 Eleven reviews
reported mixed ﬁndings, all for chronic
disease23 24 27 39 40 69 70 or stroke,31 34 52 56 and four
reported no difference in costs between intervention
and control groups for chronic disease,43 COPD,28
mental health51 or heart failure.59
The most effective interventions were based on the
CCM, with three reviews reporting signiﬁcantly reduced
costs.28 46 47 One review reported cost savings of
between 34% and 70% for CCM interventions but gave
no further detail of the nature of these savings.46
Discharge management interventions were cost-effective
in some cases,35 36 54 58 predominantly due to reduced
hospitalisation costs and fewer patient bed days. MDT
interventions that included specialist expertise also
showed some evidence for cost-effectiveness but again,
little detail was given to substantiate this.64
DISCUSSION
The primary aim of this review was to assess whether
integrated care—through interventions to coordinate
care across two or more health and/or social care set-
tings for patients with chronic diseases—can reduce hos-
pital activity and if so, to what extent. Despite the diverse
evidence base and variations within and across reviews in
terms of the characteristics, duration and intensity of
interventions, some positive trends were evident.
Overall, the most effective interventions included dis-
charge planning and postdischarge support for hospital
inpatients,53–55 57–59 MDT care—particularly when
condition-speciﬁc specialists, specialist nurses or phar-
macists were part of the team skill mix,38 63–65 and inter-
ventions based on multiple components of the
CCM,28 46–48 50 69 although no CCM reviews reported
which speciﬁc components were most likely to produce
positive outcomes. Self-management showed most
promise when incorporated into MDT care or when tai-
lored patient education was included in discharge plan-
ning.42 68 The least effective intervention was case
management. Although in theory this intervention may
increase health service efﬁciency by reducing unneces-
sary contacts with healthcare professionals,43 we found
little evidence of effectiveness. Some of the key features
of effective interventions are outlined in table 5. This
table is not intended as a ‘toolkit’ for effectiveness, since
interventions or components that reduced hospital activ-
ity for some outcomes and/or conditions were not
necessarily effective for others. Nevertheless, it sum-
marises some of the ‘ingredients’ of potentially effective
integrated care interventions.
All hospital activity outcomes showed some signiﬁcant
reductions. Proportionally, LoS was the most likely to
reduce, with 9/16 reviews reporting positive ﬁndings.
However, gains were typically modest: multicomponent
CCM strategies could reduce LoS by 2.5–4 days,46 48 and
MDT care with specialist expertise was associated with
LoS reduction of 1.5–2 days.62 66 For admissions, 11/21
reviews demonstrated positive ﬁndings, suggesting poten-
tial reductions of between 15% and 50%. Readmission
rates were signiﬁcantly reduced in 11/24 reviews, sug-
gesting a 10–30% reduction in all-cause readmission and
a 25–50% reduction in condition-speciﬁc readmission
could be achieved with interventions based on discharge
management,52–55 MDT66 and the CCM.46 48 50 69 A&E
use typically reduced by 30–40% in reviews of effective
interventions.46 60 65 It has been argued that integrated
care may increase hospital activity due to supply induced
demand, in which integration uncovers unmet patient
need.72 73 Several reviews noted minor increases in activ-
ity following case management,24 27 CCM,51 discharge
management31 and MDT interventions.39 65 However,
these increases were typically restricted to one or two
primary studies within a review and were rarely statistic-
ally signiﬁcant.
A secondary objective was to assess the settings and
patient populations for which promising interventions
may be most effective. Interventions focused on single
conditions showed greater effectiveness than those
implemented for patients with general chronic dis-
eases. Those that assessed MDT care or discharge man-
agement for patients with heart failure and COPD
were typically effective in reducing admissions,38 62–64
readmissions53–55 58 59 and LoS,62 65 66 with some posi-
tive trends evident in reducing A&E use.65 This may
reﬂect the difﬁculty of designing effective interven-
tions for people with a broad range of conditions, in a
healthcare system where care for patients with complex
needs remains largely centred on single condition
guidelines. Furthermore, interventions such as MDT
have been an established feature of disease manage-
ment for conditions like heart failure for a number of
years, and the particular success of interventions
focused on this patient group is likely to reﬂect this.
Care offered in patients’ homes, whether following dis-
charge from hospital,53 54 through MDT care,38 62 64 or
through self-management interventions42 68 was signiﬁ-
cantly associated with reduced hospital activity, particu-
larly when home care was coordinated by
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multidisciplinary outreach as opposed to a community
in-reach model. Although these interventions were
associated with signiﬁcantly reduced hospital activity,
the most successful were coordinated by the acute
sector, suggesting that effective integrated care may
still rely on the deployment of substantial hospital
resources and the involvement of multiple acute sector
healthcare professionals.
Our ﬁnal objective was to assess the cost implications
of integrated care interventions. Data were poor: the
care components that cost data referred to were often
unclear and effect sizes were rarely stated. Where statis-
tical signiﬁcance was described, the majority of savings
appeared to come from a reduction in costs incurred
through hospitalisation, whether this was because inter-
ventions allowed patients to be discharged from hos-
pital earlier or whether interventions reduced
subsequent rates of hospitalisation or rehospitalisation.
As a result, interventions which included some element
of home care or rehabilitation tended to be cost saving
compared to care in which rehabilitation was provided
within the hospital environment.28 35 42 46 47 54
However, it is likely that substantial cost savings can
only be realised if hospital capacity can be physically
removed from the system, for example, through ward
closures. We found little evidence of this following inte-
grated care interventions.
Strengths and weaknesses
This is the ﬁrst umbrella review of its kind and is timely
given the increasing emphasis on integrated care in
healthcare policy with the key aim of reducing hospital
use. By undertaking an umbrella review of systematic
reviews, we could assess a large volume of evidence
across diverse conditions, interventions and outcomes.
However, umbrella reviews have limitations. Grouping
interventions in a way that allowed meaningful conclu-
sions to be drawn about their effectiveness was challen-
ging. Although we employed the Effective Practice and
Organisation of Care Group (EPOC) taxonomy74 as an
organisational framework, few interventions were mutu-
ally exclusive and the characteristics and form of inter-
ventions frequently overlapped. For example, most
discharge management interventions were delivered by
MDT, and several interventions included some element
of self-management support. Even for reviews which
shared broadly similar intervention characteristics, the
duration of follow-up, study design, complexity, intensity
and mode of delivery varied. Furthermore, because the
unit of analysis is the review rather than the primary
study level, the re-synthesis of information at the
umbrella review level that has already been synthesised
at review level risks loss of detail or misinterpretation of
ﬁndings and trends. But, by restricting inclusion to
reviews receiving moderate, good or high QA scores, we
Table 5 Summary of intervention effectiveness
Intervention/feature* Notes/caveats
Complex interventions with multiple components ▸ Greatest effects when treating patients with single rather
than multiple conditions
▸ No reviews stated specific components that were more (or
less) likely to be effective than others
Postdischarge hospital outreach coordinated by a
multidisciplinary team
▸ Greatest effects when treating patients with single rather
than multiple conditions
▸ In contrast, community inreach interventions not effective,
even when featuring MDT
▸ Not effective for patients who had stroke
MDT with:
A. Disease-specific specialists as core members
B. Specialist nurse-led clinics
C. Pharmacists as collaborative partners
▸ Greatest effects when treating patients for single
conditions
▸ No reviews compared the ‘added value’ that a given
professional or clinician may bring to a MDT, so optimal
composition remains unknown
Transition from hospital to home is most effective when
interventions are initiated during the inpatient phase and
continue postdischarge
Home-based community follow-up ▸ Effective for reducing length of stay in patients who had
stroke
▸ Community follow-up least likely to be effective when
delivered through a case management model
Self-management education combined with multidisciplinary
approaches or discharge planning
▸ Greatest effects when treating patients for single
conditions
▸ Simple self-management interventions were largely
ineffective
*MDT, multidisciplinary team.
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reduced the likelihood of evidence misinterpretation
and the incidence of discordant ﬁndings. Successful
approaches to integrated care have highly context-
speciﬁc histories, yet by undertaking an umbrella review,
we were unable to draw conclusions about the speciﬁc
contexts in which interventions were implemented.
Nevertheless, we believe that the methodological
strengths of our approach outweigh the limitation of
being unable to comment on the speciﬁc contexts in
which interventions were implemented.
Implications for clinicians and policymakers
Although there was evidence that some integrated care
interventions can reduce hospital activity, effects were
rarely unequivocally positive. The size of gains from inte-
gration may also be modest.17 For example, in recent
years, the trend in outcomes such as length of hospital
stay has been steadily reducing, largely due to improved
surgical techniques and increased day case treatment.8
This suggests that there may be limits to the absolute
reductions in key hospital activity metrics that integrated
care initiatives could achieve.1 This was evident in
several reviews that noted statistically signiﬁcant differ-
ences in outcomes for intervention versus control
patients, but which reported persistently high absolute
rates of outcomes such as admissions and readmissions
in each group.48 52 54 58 65 68
This has implications for the potential success of policy
initiatives designed to reduce hospital activity. In
England, integration has become a central feature of the
evolving healthcare policy landscape and there are high
expectations of substantial beneﬁts from integrating care.
The BCF and ‘Vanguard’ sites7 have been developed fol-
lowing recognition that radically different models of care
are needed if the NHS in England is to overcome its
growing challenges, and both policy initiatives involve far-
reaching change to health and social care services with
the aim of meeting national headline targets for reduced
hospital and emergency care use.75 Interventions shown
to be effective in this review have much in common with
the rationale behind the BCF—care provided in the com-
munity rather than in hospitals was shown in many cases
to be highly effective. Multidisciplinary care, discharge
planning and self-management educating patients on
identifying symptoms of exacerbation of their condition
(s) all have the potential to improve outcomes and
reduce activity at the ‘back door’ and ‘front door’ of the
acute sector. Disease-speciﬁc expertise was also found in
many reviews to be crucial to the success of integrated
care interventions, as was secondary care outreach to
other settings. This bodes well for BCF and Vanguard
initiatives built around these interventions. However, it is
of concern that many vanguard sites aim to integrate care
via a case management approach, which showed the
poorest evidence of effectiveness in our review. This
raises questions over whether the Vanguard strategies will
be able to deliver the outcome improvements they are
being established to achieve. The extent to which
integrated care can bring about signiﬁcant cost savings in
a health system beset with ongoing budgetary constraints
is also highly uncertain.
Interventions designed for single conditions were sub-
stantially more effective than those designed to treat
patients with chronic diseases in general terms. On one
hand, this suggests that service providers can achieve
some ‘quick wins’ by targeting interventions such as dis-
charge planning and specialist MDT towards speciﬁc
patient groups in whom the evidence for reduced hos-
pital use is clear. On the other hand, this means that
integration may not deliver the substantial reductions in
acute sector activity that must be achieved if healthcare
services are to remain sustainable in the longer term.
Unanswered questions and future research
Integrated care poses challenges to the measurement of
‘hard’ healthcare service outcomes in what are often
complex intervention programmes. Determining cause
and effect is difﬁcult when interventions include multiple
components, yet being able to link a speciﬁc intervention
to a particular observed outcome is typically central to
policymaking and commissioning objectives. Research to
develop a robust taxonomy for integrated care interven-
tions and their components would make assessments of
comparative effectiveness across interventions less challen-
ging. We attempted to maximise the relevance of review
ﬁndings to the English health and social care system by
considering interventions implemented in developed
economies, but further research is needed to determine
whether interventions found to be effective in other
healthcare systems can be generalised to the NHS. In par-
ticular, robust evaluations would allow the inﬂuence of
local and organisational contexts to be disentangled from
the effects of the intervention themselves, as although
the umbrella review gives some indication about ‘what’
might work, it does not necessarily help our understand-
ing of ‘how’ an intervention works and why it may work
in some circumstances and not others.
Few reviews explicitly addressed multimorbidity, which
has recently become of central importance in debates
about hospital use by patients with complex needs.4 76
Further research is needed to understand the issues faced
by patients with multimorbidity when negotiating the
health and social care system.77 Similarly, despite our
comprehensive search strategy, the evidence base focused
little on the role of primary care, social care or the volun-
tary sector in providing integrated services. Given current
policy drivers towards services being provided in the com-
munity by GPs and other organisations rather than acute
providers, further research to assess the implications of
integrated care for the organisation and delivery of ser-
vices in these sectors is urgently needed.
CONCLUSIONS
This review highlights a number of potentially effective
integrated care interventions to reduce hospital use for
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patients with chronic diseases. Interventions based on
MDT that include condition specialists, those focused
on discharge management that include postdischarge
rehabilitation and follow-up and those based on multi-
component strategies were most likely to be associated
with signiﬁcant reductions in hospital use for patients
with single conditions such as heart failure and COPD.
Yet there was little robust evidence about potential cost
efﬁciencies, and the effectiveness of care delivered in
primary and social care settings remains largely
unknown. Despite considerable fanfare accompanying
efforts to integrate care across the health and social care
system in England, integration does not seem to be a
‘magic bullet’ and the magnitude of achievable gains is
unlikely to match those required by current policy
targets.
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